Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of intra-articular corticosteroid injection with or without suprascapular nerve block in adhesive capsulitis
2026-525317-31-00Phase 2Authorised
- Sponsor
- CHU de Nantes
- Start
- Sep 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of betamethasone in adhesive capsulitis (AC) (2 arms), sponsored by CHU de Nantes. Primary endpoint: Change in QuickDASH score from baseline to Month 3. Planned start Sep 2026; status: authorised.
02
Drugs
betamethasone
03
Conditions
adhesive capsulitis (AC)
Beyond the preview
Go deeper on 2026-525317-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-525317-31-00.